文献速递生殖医学

ART-ET筛查工具:一种简便的非侵入性筛查方法用于提前预测困难胚胎移植

The ART-ET screening tool: an easy-to-use non-invasive screening method to predict difficult embryo transfers in advance.
PubMed 文献 · Hum Reprod · 2025-01-01

该诊断试验研究于2023年3月至12月前瞻性纳入239例单整倍体囊胚移植,评估ART-ET筛查工具预测困难胚胎移植的诊断性能。包含宫颈位置、宫颈管可见性及长度和产科史的评分特异度99.5%、准确率93.7%;仅宫颈超声评分特异度98.2%、准确率93.5%。

要点

  • 包含宫颈位置、宫颈管可见性及长度和产科史的评分预测困难移植特异度99.5%、准确率93.7%。
  • 仅宫颈超声评分预测困难移植特异度98.2%、准确率93.5%,阳性预测值60.0%。
  • 困难移植后持续妊娠率47.6% vs 容易移植后59.6%。

核心结论

  • 宫颈管经阴道超声的简单评分可以高特异度、高阳性似然比和高准确率预测困难胚胎移植。
  • 纳入宫颈位置和无阴道分娩的剖宫产史可改善预测性能。

研究设计与样本

  • 诊断试验研究,于2023年3月至12月前瞻性纳入239例单整倍体囊胚移植,样本量计算拟纳入约20例困难移植。
  • 研究在两个三级私立辅助生殖中心进行,操作移植的医生对筛查结果设盲。

主要发现

  • 困难移植后持续妊娠率为47.6% vs 容易移植后59.6%。
  • 困难胚胎移植发生率为8.8%。
  • 包含宫颈位置、宫颈管可见性及长度和产科史的评分:敏感度33.3%(14.59-56.97%)、特异度99.5%(97.47-99.99%)、阳性似然比72.67(9.38-562.73)、阴性似然比0.67(0.49-0.91)、准确率93.7%(89.86-96.45%)。
  • 仅宫颈超声评分:敏感度28.6%(11.28-52.18%)、特异度98.2%(95.37-99.50%)、阳性似然比15.57(4.77-50.84)、阴性似然比0.73(0.55-0.95)、阳性预测值60.0%(31.46-83.03%)、阴性预测值93.5%(91.59-94.93%)、准确率93.5%(91.59-94.93%)。
  • 困难胚胎移植定义为术中发生以下一项或多项:使用可弯探针将引导导管插入至宫颈内口、使用钳子牵拉宫颈、术后移植导管有血、移植导管需重新装载、医生认为操作困难。

关键数值与推荐

  • ART-ET筛查工具收集患者体重指数、产科史、宫颈位置、宫颈外口外观及宫颈管超声检查信息。

临床怎么用

  • 作者认为,预判困难移植有助于调整患者预期并提前采取适当措施。

局限性

  • 所提出的ART-ET筛查工具的诊断性能取决于各诊所困难胚胎移植的发生率。
  • 评分系统能在多大程度上减少困难胚胎移植并改善活产率需在进一步研究中确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the diagnostic performance of the ART-ET screening tool, an easy-to-use non-invasive screening tool for prediction of difficult embryo transfers? SUMMARY ANSWER: A simple scoring of transvaginal ultrasound examination of the cervical canal can predict difficult embryo transfers with high specificity, positive likelihood ratio, and accuracy; the inclusion of cervical position and history of cesarean without a vaginal delivery improved predictive performance. WHAT IS KNOWN ALREADY: Difficult embryo transfer procedures are associated with significantly lower clinical pregnancy and live birth rates, and some interventions may facilitate an anticipated difficult embryo transfer. STUDY DESIGN, SIZE, DURATION: A diagnostic test study prospectively conducted on 239 single euploid blastocyst transfer procedures between March and December 2023. The sample size was calculated to include about 20 difficult transfer procedures. Physicians conducting the transfers were blinded to screening results. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted in two tertiary-level private assisted reproduction centers. The ART-ET Screening tool collected information on patients' body mass index, obstetric history, cervical position, external cervical ostium appearance, and ultrasound examination of the cervical canal. A difficult embryo transfer was defined if one or more of the following occurred during the procedure; use of a malleable obturator to insert the guiding catheter until the internal ostium, use of a forceps to pull the cervix, if there were blood in the transfer catheter following the procedure, if the transfer catheter needed to be reloaded, and if the physician found the procedure difficult. MAIN RESULTS AND THE ROLE OF CHANCE: Ongoing pregnancy rates were 47.6% vs 59.6% after a difficult and easy embryo transfer. With a difficult embryo transfer prevalence of 8.8%, screening score including cervical position, visibility and the length of cervical canal, and obstetric history had the best diagnostic performance with sensitivity of 33.3% (14.59-56.97%), specificity of 99.5% (97.47-99.99%), positive likelihood ratio of 72.67 (9.38-562.73), negative likelihood ratio of 0.67 (0.49-0.91), and an accuracy of 93.7% (89.86-96.45%) for predicting difficult embryo transfers. The simpler cervical ultrasound score also had a good diagnostic performance with a sensitivity of 28.6% (11.28-52.18%), specificity of 98.2% (95.37-99.50%), positive likelihood ratio of 15.57 (4.77-50.84), negative likelihood ratio of 0.73 (0.55-0.95), positive predictive value of 60.0% (31.46-83.03%), negative predictive value of 93.5% (91.59-94.93%), and an accuracy of 93.5% (91.59-94.93%). LIMITATIONS, REASONS FOR CAUTION: The diagnostic performance of the proposed ART-ET Screening tool would depend on the prevalence of difficult embryo transfers in a clinic. How much the scoring system can decrease difficult embryo transfers and improve live birth rates need to be determined in further studies. WIDER IMPLICATIONS OF THE FINDINGS: Anticipation of a difficult transfer can help to adjust patient expectations and to take appropriate measures in advance. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for the study. None of the authors have any competing interests associated with the present study. TRIAL REGISTRATION NUMBER: NCT05701072.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ata B, Lawrenz B, Melado L, et al. The ART-ET screening tool: an easy-to-use non-invasive screening method to predict difficult embryo transfers in advance. Hum Reprod. 2025. PMID: 39938557. doi:10.1093/humrep/deaf002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。